Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Covington
UBS
Mallinckrodt
Johnson and Johnson
Julphar
Chubb
US Army
McKinsey

Generated: November 13, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Remimazolam

« Back to Dashboard

US Patents for Remimazolam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepines CeNeS Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepines CeNeS Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepines CeNes Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepines CeNes Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepines CeNes Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Short-acting benzodiazepine salts and their polymorphic forms PAION UK Limited (Cambridge, GB) ➤ Try a Free Trial
Remimazolam ➤ Try a Free Trial Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiaze- pine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process PAION UK LIMITED (Cambridge, GB) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Remimazolam

Drugname Country Document Number Estimated Expiration Related US Patent
Remimazolam Austria 317390 2019-05-14 ➤ Try a Free Trial
Remimazolam Australia 4846300 2019-05-14 ➤ Try a Free Trial
Remimazolam Germany 60025921 2019-05-14 ➤ Try a Free Trial
Remimazolam Denmark 1183243 2019-05-14 ➤ Try a Free Trial
Remimazolam European Patent Office 1183243 2019-05-14 ➤ Try a Free Trial
Remimazolam Spain 2258008 2019-05-14 ➤ Try a Free Trial
Remimazolam United Kingdom 9911152 2019-05-14 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Harvard Business School
Cerilliant
Chubb
McKinsey
Julphar
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.